Combining TIGIT blockade with IL‐15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma. - Luo, Baohong; Sun, Yu; Zhan, Qinru; Luo, Yuting; Chen, Yu; Fu, Tongze; Yang, Tiantian; Ren, Lijuan; Xie, Zhongpeng; Situ, Xiaohua; Liu, Bixia; Tang, Kejing; et al. (Clinical & Translational Medicine, 2024)